Preface ....................................................... vii
Contributors ................................................... xi
List of Color Plates ......................................... xiii
1. An Overview of Compounds That Interact with Tubulin
and Their Effects on Microtubule Assembly .................... 1
Ernest Hamel
2. Molecular Mechanisms of Microtubule Acting
Cancer Drugs ................................................ 21
John J.Correia and Sharon Lobert
3. Microtubule Dynamics: Mechanisms and Regulation
by Microtubule-Associated Proteins and Drugs In Vitro
and in Cells ................................................ 47
Mary Ann Jordan and Leslie Wilson
4. Microtubule Associated Proteins and Micro tubule-
Interacting Proteins: Regulators of Microtubule
Dynamics .................................................... 83
Maria Kavallaris, Sima Don, and Nicole M.Verrills
5. The Post-Translational Modifications of Tubulin ............ 105
Richard F.Luduena and Asok Banerjee
6. The Isotypes of Tubulin: Distribution
and Functional Significance ................................ 123
Richard F.Luduena and Asok Banerjee
7. The Tubulin Superfamily .................................... 177
Richard F.Luduena and Asok Banerjee
8. Tubulin Proteomics in Cancer ............................... 193
Pascal Verdier-Pinard, Fang Wang, Ruth Hogue
Angeletti, Susan Band Horwitz, and George A.Orr
9. Tubulin and Microtubule Structures ......................... 211
Eva Nogales and Kenneth H.Downing
10.Destabilizing Agents: Peptides and Depsipeptides ........... 227
Lee M.Greenberger and Frank Loganzo
11.Molecular Features of the Interaction of
Colchicine and Related Structures with Tubulin ............. 259
Susan L.Bane
12.Antimicrotubule Agents That Bind Covalently
to Tubulin ................................................. 281
Dan L.Sackett
13.Microtubule Stabilizing Agents ............................. 307
Susan Band Horwitz and Tito Fojo
14.Mechanisms of Resistance to Drugs That Interfere
with Microtubule Assembly .................................. 337
Fernando Cabral
15.Resistance to Microtubule-Targeting Drugs .................. 357
Paraskevi Giannakakou and James P.Snyder
16.Microtubule Stabilizing Agents in Clinical
Oncology: The Taxanes ...................................... 395
Chris H.Takimoto and Muralidhar Beeram
17.Investigational Anticancer Agents Targeting
the Microtubule ............................................ 421
Lyudmila A.Vereshchagina, Orit Scharf,
and A.Dimitrios Colevas
18.Microtubule Damaging Agents and Apoptosis .................. 479
Manon Carre and Diane Braguer
19.Microtubule Targeting Agents and the
Tumor Vasculature .......................................... 519
Raffaella Giavazzi, Katiuscia Bonezzi, and
Giulia Taraboletti
20.Neurodegenerative Diseases: Таи Proteins in
Neurodegenerative Diseases Other Than AD ................... 531
André Delacourte, Nicolas Sergeant, and Luc Buée
21.Structure, Function, and Regulation of the Microtubule
Associated Protein Tau ..................................... 559
Janis Bunker and Stuart C. Feinstein
Index ......................................................... 577
|